Osamu Ohara Selected Research

Nasal Polyps (Nasal Polyp)

1/2020	Cysteinyl leukotriene metabolism of human eosinophils in allergic disease.
1/2019	Dysregulated fatty acid metabolism in nasal polyp-derived eosinophils from patients with chronic rhinosinusitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Osamu Ohara Research Topics

Disease

27	Neoplasms (Cancer) 11/2022 - 10/2003
14	Inflammation (Inflammations) 01/2022 - 10/2009
12	Infections 04/2023 - 12/2010
7	Virus Diseases (Viral Diseases) 01/2022 - 12/2011
7	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 08/2011
6	Leukemia 02/2016 - 05/2009
5	Primary Immunodeficiency Diseases 01/2019 - 01/2009
4	Cryopyrin-Associated Periodic Syndromes 01/2024 - 04/2012
4	Rheumatoid Arthritis 01/2023 - 05/2014
4	Asthma (Bronchial Asthma) 10/2020 - 05/2014
3	Fibrosis (Cirrhosis) 03/2024 - 01/2017
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 10/2021
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 04/2006
3	Pemphigus (Pemphigus Vulgaris) 10/2023 - 01/2020
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2023 - 12/2010
3	Bruton type agammaglobulinemia 10/2022 - 02/2015
3	Common Variable Immunodeficiency 10/2022 - 05/2013
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 08/2011
3	Chronic Granulomatous Disease 01/2021 - 05/2013
3	Job Syndrome (Hyper-IgE Syndrome) 01/2021 - 12/2014
3	Dermatitis 01/2021 - 01/2016
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2013
3	Chronic Mucocutaneous Candidiasis 12/2020 - 08/2012
3	Rhinosinusitis 10/2020 - 01/2019
3	Fever (Fevers) 01/2020 - 07/2014
3	Obesity 11/2018 - 07/2011
3	Adenocarcinoma 01/2018 - 12/2004
3	Carcinoma (Carcinomatosis) 01/2017 - 10/2003
3	Lung Neoplasms (Lung Cancer) 01/2017 - 11/2010
3	Wiskott-Aldrich Syndrome 11/2015 - 02/2013
3	Contact Dermatitis (Eczema, Contact) 05/2015 - 04/2003
2	COVID-19 10/2022 - 01/2022
2	Pneumonia (Pneumonitis) 10/2022 - 05/2014
2	2 X-Linked Lymphoproliferative Syndrome 01/2022 - 10/2021
2	Hepatitis 01/2022 - 12/2012
2	Thrombocytopenia (Thrombopenia) 08/2021 - 02/2013
2	Rare Diseases (Rare Disease) 07/2021 - 01/2008
2	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 04/2010
2	IRAK4 Deficiency 01/2021 - 01/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 12/2017
2	Fatty Liver 11/2020 - 07/2013
2	Colorectal Neoplasms (Colorectal Cancer) 06/2020 - 01/2018
2	Nasal Polyps (Nasal Polyp) 01/2020 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019 - 01/2018
2	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 10/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2003
9	CytokinesIBA 09/2023 - 10/2009
8	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2016
8	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 04/2012
6	AntigensIBA 01/2020 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2014
5	ProteomeIBA 07/2023 - 11/2020
5	ChemokinesIBA 01/2018 - 04/2003
4	AutoantibodiesIBA 10/2023 - 04/2013
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2014
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 11/2021 - 01/2004
4	InterferonsIBA 01/2020 - 11/2010
4	Immunoglobulins (Immunoglobulin)IBA 11/2018 - 05/2013
4	LigandsIBA 01/2018 - 12/2011
3	SteroidsIBA 01/2022 - 01/2004
3	Immunoglobulin M (IgM)IBA 01/2022 - 04/2013
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 05/2014
3	Interleukin-4 (Interleukin 4)IBA 01/2022 - 05/2014
3	ZincIBA 01/2022 - 08/2014
3	Interleukin-5 (Interleukin 5)IBA 12/2021 - 01/2013
3	STAT1 Transcription FactorIBA 12/2020 - 07/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 01/2019
2	InterleukinsIBA 01/2024 - 01/2022
2	Interleukin-1 (Interleukin 1)IBA 01/2024 - 01/2021
2	DesmogleinsIBA 10/2023 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 12/2021
2	Interferon Type IIBA 10/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 12/2021
2	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2022 - 10/2021
2	Desmoglein 3IBA 01/2022 - 01/2020
2	EnzymesIBA 12/2021 - 01/2019
2	Complement System Proteins (Complement)IBA 07/2021 - 10/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 07/2012
2	VaccinesIBA 01/2021 - 03/2016
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2006
2	PyrinIBA 01/2021 - 04/2010
2	AntibodiesIBA 01/2021 - 12/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020 - 01/2020
2	Peptides (Polypeptides)IBA 06/2020 - 02/2016
2	A-Form DNA (A-DNA)IBA 01/2020 - 12/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2014
2	CollagenIBA 01/2019 - 01/2017
2	InflammasomesIBA 01/2019 - 01/2015
2	CD40 Ligand (CD40L)IBA 10/2018 - 01/2018

Therapy/Procedure

15	Therapeutics 04/2023 - 11/2010
5	Immunotherapy 01/2017 - 01/2016
4	Hematopoietic Stem Cell Transplantation 01/2019 - 05/2009
3	Transplantation 11/2021 - 10/2005
2	Aftercare (After-Treatment) 10/2023 - 01/2019
2	Cell Transplantation 04/2023 - 10/2021
2	Stem Cell Transplantation 03/2019 - 03/2016